Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Asthma treatment with glucocorticoid inhalants during pregnancy and pediatric diseases in the offspring : A Danish national cohort study
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 2277818
Author(s) Tegethoff, Marion; Greene, Naomi; Olsen, Jorn; Schaffner, Emmanuel; Meinlschmidt, Gunther
Author(s) at UniBasel Meinlschmidt, Gunther
Year 2012
Title Asthma treatment with glucocorticoid inhalants during pregnancy and pediatric diseases in the offspring : A Danish national cohort study
Journal American Journal of Respiratory and Critical Care Medicine
Volume 185
Number 5
Pages / Article-Number 557-563
Keywords antenatal, corticosteroids, inhaled, prenatal exposure delayed effects, programming
Abstract Rationale: Glucocorticoid inhalation is the preferred asthma treatment during pregnancy. Previous studies on its safety focused on obstetric outcomes and offspring malformations.Objectives: To determine whether glucocorticoid inhalation during pregnancy is a risk factor for offspring pediatric diseases.Methods: We studied offspring (live singletons) of pregnant women suffering from asthma during pregnancy (prevalence = 6.3%; n = 4,083 mother-child pairs) from the Danish National Birth Cohort (births, 1996-2002; prospective data). We estimated the associations between use of inhaled glucocorticoids for asthma treatment during pregnancy (n = 1231; 79.9% budesonide, 17.6% fluticasone, 5.4% beclomethasone, and 0.9% other or unspecified glucocorticoids) and offspring diseases (International Classification of Diseases-10th Revision, diagnoses) during childhood. We conducted Cox or logistic regression analyses for each International Classification of Diseases-10th Revision category, controlling for use of non-glucocorticoid-containing inhalants, and confirmed results by addressing confounding by treatment indication using propensity score.Measurements and Main Results: Offspring median age at end of follow-up was 6.1 (range, 3.6-8.9) years. Glucocorticoid inhalation was not associated with offspring disease risk in most categories, except for offspring endocrine, metabolic, and nutritional disorders (hazard ratio, 1.84; 95% confidence interval, 1.13-2.99). When repeating analyses with the major subgroup that used budesonide only, association estimates were of similar magnitude.Conclusions: Regarding most disease categories, data are reassuring, supporting the use of inhaled glucocorticoids during pregnancy. In line with animal data, glucocorticoid inhalation during pregnancy may be a risk factor for offspring endocrine and metabolic disturbances, which should be considered further.
Publisher American Thoracic Society
ISSN/ISBN 0003-0805
edoc-URL http://edoc.unibas.ch/dok/A6205405
Full Text on edoc No
Digital Object Identifier DOI 10.1164/rccm.201108-1482OC
ISI-Number WOS:000300858400016
Document type (ISI) Article
 
   

MCSS v5.8 PRO. 0.320 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
19/04/2024